June 18, 2020 / 12:10 PM / 21 days ago

BRIEF-Seattle Genetics Announces Initiation Of Phase 1 Clinical Trials For Two Novel Antibody-Based Drug Candidates

June 18 (Reuters) - Seattle Genetics Inc:

* SEATTLE GENETICS ANNOUNCES INITIATION OF PHASE 1 CLINICAL TRIALS FOR TWO NOVEL ANTIBODY-BASED DRUG CANDIDATES

* SEATTLE GENETICS INC - TWO NOVEL ANTIBODY-BASED DRUG CANDIDATES TO BE EVALUATED IN MULTIPLE TUMOR TYPES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below